Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-13-162909
Filing Date
2013-04-19
Accepted
2013-04-19 16:19:45
Documents
9
Period of Report
2013-06-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A d524974dpre14a.htm PRE 14A 345160
2 GRAPHIC g524974g01c85.jpg GRAPHIC 9088
3 GRAPHIC g524974pc_001anew.jpg GRAPHIC 7056
4 GRAPHIC g524974pc_001bnew.jpg GRAPHIC 22063
5 GRAPHIC g524974pc_001cnew.jpg GRAPHIC 33554
6 GRAPHIC g524974pc_001d.jpg GRAPHIC 1266
7 GRAPHIC g524974pc_001e.jpg GRAPHIC 1386
8 GRAPHIC g524974pc_001f.jpg GRAPHIC 15406
9 GRAPHIC g524974pc_001gnew.jpg GRAPHIC 34261
  Complete submission text file 0001193125-13-162909.txt   518647
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33958 | Film No.: 13771815
SIC: 2834 Pharmaceutical Preparations